![Petr Kocis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Petr Kocis has worked as a Vice President-Preclinical Development at Alzheon, Inc. since 2015.
Aktive Positionen von Petr Kocis
Unternehmen | Position | Beginn |
---|---|---|
ALZHEON, INC. | Corporate Officer/Principal | 01.01.2015 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Alzheon, Inc.
![]() Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |